Dr. Brian Patel, Chief of Emergency Medicine at Sturdy Memorial Hospital, and Deborah Jean Parsons, Ph.D. Director of Integrated Care at Aspire Health Alliance, share actionable best practices for developing better community partnerships to support patients struggling with complex comorbid physical, behavioral, mental, and SDOH challenges.

Abbott Laboratories won U.S. marketing approval for a diagnostic test for the coronavirus that can deliver results to patients within minutes and be used in physicians’ offices and urgent care clinics, as well as hospitals.

Caring for patients with complex physical, behavioral, and mental health conditions requires a community effort—especially when those patients also face social determinants of health. Learn how communities are working together to achieve over 100% growth in patient engagement and a 78% reduction in ED utilization through care collaboration.

California ordered nearly 40 million people to stay home and New York state on Friday told all non-essential workers to do the same while pleading for more medical personnel and supplies to treat coronavirus cases that could overwhelm hospitals.

Allecra Therapeutics indicated the company’s Exblifep (cefepime-enmetazobactam) hit pre-specified primary endpoints in the Phase III ALLIUM clinical trial in complicated urinary tract infections, including acute pyelonephritis.

Hospital groups challenged the Trump administration’s rule that requires hospitals to be more transparent about prices they charge patients for healthcare services, according to a filed lawsuit.

Merck & Co. Inc.’s experimental treatment vericiguat being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.

The U.S. FDA approved Janssen’s Xarelto (rivaroxaban) for preventing blood clots in acutely sick patients in hospitals who are at risk for blood clots but who are not at high risk of bleeding.

Eight drug companies urged a federal appeals court to disqualify the judge overseeing nationwide opioid litigation, in a last-ditch effort to avoid having him preside over a landmark trial.

Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital launched a joint laboratory to research new drugs to treat chronic lung diseases.